These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8630009)

  • 1. Promoter variation in the liver glucokinase is a risk factor for non-insulin-dependent diabetes mellitus.
    Chiu KC; McCarthy JE
    Biochem Biophys Res Commun; 1996 Apr; 221(3):614-8. PubMed ID: 8630009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved metabolic disorders of insulin receptor-deficient mice by transgenic overexpression of glucokinase in the liver.
    Jackerott M; Baudry A; Bucchini D; Jami J; Joshi RL
    Diabetologia; 2002 Sep; 45(9):1292-7. PubMed ID: 12242462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor VII gene polymorphisms, factor VII:C levels and features of insulin resistance in non-insulin-dependent diabetes mellitus.
    Heywood DM; Mansfield MW; Grant PJ
    Thromb Haemost; 1996 Mar; 75(3):401-6. PubMed ID: 8701397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the glucokinase gene promoter in Japanese subjects with noninsulin-dependent diabetes mellitus.
    Shimokawa K; Sakura H; Otabe S; Eto K; Kadowaki H; Hagura R; Yazaki Y; Akanuma Y; Kadowaki T
    J Clin Endocrinol Metab; 1994 Sep; 79(3):883-6. PubMed ID: 8077376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of polymorphism of the GLUT2 promoter in NIDDM patients and its functional consequence to the promoter activity.
    Cha JY; Kim HS; Kim HI; Im SS; Kim SY; Kim JW; Yeh BI; Ahn YH
    Ann Clin Lab Sci; 2002; 32(2):114-22. PubMed ID: 12017192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucokinase gene islet promoter region variant (G-->A) at nucleotide -30 is not associated with reduced insulin secretion in Finns.
    Rissanen J; Saarinen L; Heikkinen S; Kekäläinen P; Mykkänen L; Kuusisto J; Deeb SS; Laakso M
    Diabetes Care; 1998 Jul; 21(7):1194-7. PubMed ID: 9653619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel variant in the phosphoenolpyruvate carboxykinase gene promoter in Japanese patients with type 2 diabetes.
    Horikawa Y; Yamasaki T; Nakajima H; Shingu R; Yoshiuchi I; Miyagawa J; Namba M; Hanafusa T; Matsuzawa Y
    Horm Metab Res; 2003 May; 35(5):308-12. PubMed ID: 12916001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of the impact of a liver glucokinase promoter variant on glucose tolerance and insulin sensitivity index.
    Urhammer SA; Hansen T; Jensen LB; Clausen JO; Hansen L; Chui KC; Pedersen O
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1786-9. PubMed ID: 9177383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examination of the phosphoenolpyruvate carboxykinase gene promoter in patients with noninsulin-dependent diabetes mellitus.
    Ludwig DS; Vidal-Puig A; O'Brien RM; Printz RL; Granner DK; Moller DE; Flier JS
    J Clin Endocrinol Metab; 1996 Feb; 81(2):503-6. PubMed ID: 8636258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the -514C-->T polymorphism in the hepatic lipase gene (LIPC) promoter with elevated fasting insulin concentrations, but not insulin resistance, in non-diabetic Germans.
    Machicao F; Staiger H; Fritsche A; Guirguis A; Weisser M; Stumvoll M; Häring HU
    Horm Metab Res; 2004 May; 36(5):303-6. PubMed ID: 15156410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A series of maturity onset diabetes of the young, type 2 (MODY2) mouse models generated by a large-scale ENU mutagenesis program.
    Inoue M; Sakuraba Y; Motegi H; Kubota N; Toki H; Matsui J; Toyoda Y; Miwa I; Terauchi Y; Kadowaki T; Shigeyama Y; Kasuga M; Adachi T; Fujimoto N; Matsumoto R; Tsuchihashi K; Kagami T; Inoue A; Kaneda H; Ishijima J; Masuya H; Suzuki T; Wakana S; Gondo Y; Minowa O; Shiroishi T; Noda T
    Hum Mol Genet; 2004 Jun; 13(11):1147-57. PubMed ID: 15102714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mutation screening of GCK gene in Chinese early-onset diabetes population].
    Zheng TS; Wu SH; Yang Z; Lu HJ; Xiang KS
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Dec; 22(6):671-4. PubMed ID: 16331569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Non-insulin dependent diabetes in children and adolescents].
    Njølstad PR; Søvik O; Bell GI; Cockburn BN; Følling I; Sagen J
    Tidsskr Nor Laegeforen; 1998 Mar; 118(7):1054-7. PubMed ID: 9531829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the TNF-alpha -308 G/A promoter polymorphism with insulin resistance in obesity.
    Dalziel B; Gosby AK; Richman RM; Bryson JM; Caterson ID
    Obes Res; 2002 May; 10(5):401-7. PubMed ID: 12006640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular genetic analysis of NIDDM. Status and prospects.
    Poller W; Schatz H
    Exp Clin Endocrinol; 1993; 101(2):58-68. PubMed ID: 8405141
    [No Abstract]   [Full Text] [Related]  

  • 16. Impaired activity and gene expression of hexokinase II in muscle from non-insulin-dependent diabetes mellitus patients.
    Vestergaard H; Bjørbaek C; Hansen T; Larsen FS; Granner DK; Pedersen O
    J Clin Invest; 1995 Dec; 96(6):2639-45. PubMed ID: 8675629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In search of the genes responsible for NIDDM].
    Laakso M
    Duodecim; 1996; 112(4):336-7. PubMed ID: 10590650
    [No Abstract]   [Full Text] [Related]  

  • 18. On the pathophysiology of late onset non-insulin dependent diabetes mellitus. Current controversies and new insights.
    Vaag A
    Dan Med Bull; 1999 Jun; 46(3):197-234. PubMed ID: 10421979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G/A polymorphism at -258 of the hepatic glucokinase promoter is not associated with decreased birth weight in preterm neonates.
    Pawlowski M; Kouklinos A; Jopp-Petzina G; Herkenrath P; Fischer M; Kribs A; Roth B; Roth J; Tenbrock K
    Neonatology; 2008; 94(2):71-4. PubMed ID: 18196929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The G-250A substitution in the promoter region of the hepatic lipase gene is associated with the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.
    Zacharova J; Todorova BR; Chiasson JL; Laakso M;
    J Intern Med; 2005 Feb; 257(2):185-93. PubMed ID: 15656877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.